161 related articles for article (PubMed ID: 8487239)
21. [Continuous postmenopausal estrogen-progesterone therapy].
Affinito P; Tommaselli GA; Morgera R; Rinaldi M; Di Mauro P; Nappi C
Minerva Ginecol; 1993 Mar; 45(3):77-85. PubMed ID: 8392669
[TBL] [Abstract][Full Text] [Related]
22. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
23. Lipid changes after hormone replacement therapy for menopause.
Kable WT; Gallagher JC; Nachtigall L; Goldgar D
J Reprod Med; 1990 May; 35(5):512-8. PubMed ID: 2112606
[TBL] [Abstract][Full Text] [Related]
24. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
[TBL] [Abstract][Full Text] [Related]
25. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group.
Lobo RA; Pickar JH; Wild RA; Walsh B; Hirvonen E
Obstet Gynecol; 1994 Dec; 84(6):987-95. PubMed ID: 7970483
[TBL] [Abstract][Full Text] [Related]
26. Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement.
Williams DB; Voigt BJ; Fu YS; Schoenfeld MJ; Judd HL
Obstet Gynecol; 1994 Nov; 84(5):787-93. PubMed ID: 7936513
[TBL] [Abstract][Full Text] [Related]
27. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
[TBL] [Abstract][Full Text] [Related]
28. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
29. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Ursin G; Palla SL; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Greendale GA
J Clin Oncol; 2004 Jul; 22(14):2842-8. PubMed ID: 15254051
[TBL] [Abstract][Full Text] [Related]
30. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
[TBL] [Abstract][Full Text] [Related]
31. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.
Barrett-Connor E; Young R; Notelovitz M; Sullivan J; Wiita B; Yang HM; Nolan J
J Reprod Med; 1999 Dec; 44(12):1012-20. PubMed ID: 10649811
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
[TBL] [Abstract][Full Text] [Related]
33. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
Bunyavejchevin S; Limpaphayom KK
J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
[TBL] [Abstract][Full Text] [Related]
34. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[TBL] [Abstract][Full Text] [Related]
35. Comparison of continuous versus sequential estrogen and progestin therapy in postmenopausal women.
Clisham PR; de Ziegler D; Lozano K; Judd HL
Obstet Gynecol; 1991 Feb; 77(2):241-6. PubMed ID: 1846438
[TBL] [Abstract][Full Text] [Related]
36. Metabolic effects of continuous estradiol-progestin therapy in postmenopausal women.
Sporrong T; Hellgren M; Samsioe G; Mattsson LA
Obstet Gynecol; 1989 May; 73(5 Pt 1):754-8. PubMed ID: 2704503
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient.
Weinstein L; Bewtra C; Gallagher JC
Am J Obstet Gynecol; 1990 Jun; 162(6):1534-9; discussion 1539-42. PubMed ID: 2360587
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy.
Kirkham C; Hahn PM; Van Vugt DA; Carmichael JA; Reid RL
Obstet Gynecol; 1991 Jul; 78(1):93-7. PubMed ID: 1828550
[TBL] [Abstract][Full Text] [Related]
39. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women.
Hickok LR; Toomey C; Speroff L
Obstet Gynecol; 1993 Dec; 82(6):919-24. PubMed ID: 8233265
[TBL] [Abstract][Full Text] [Related]
40. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women.
Magos AL; Brincat M; Studd JW; Wardle P; Schlesinger P; O'Dowd T
Obstet Gynecol; 1985 Apr; 65(4):496-9. PubMed ID: 2984616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]